If you would like to ask our webinar guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund a question please submit them here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksInc&gwth Vct Regulatory News (IGV)

Share Price Information for Inc&gwth Vct (IGV)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 70.00
Bid: 68.50
Ask: 71.50
Change: 0.00 (0.00%)
Spread: 3.00 (4.38%)
Open: 70.00
High: 70.00
Low: 70.00
Prev. Close: 70.00
IGV Live PriceLast checked at -
The Income & Growth VCT is an Investment Trust

To provide an attractive return by maximising dividend distributions from the income and capital gains generated by investment in unquoted companies. This may include AIM companies.

Find out More

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Interim Management Statement - 1st Quarter

20 Feb 2020 11:00

RNS Number : 6207D
Income & Growth VCT (The) PLC
20 February 2020
 

The Income & Growth VCT plc

(the "Company")

 

INTERIM MANAGEMENT STATEMENT

For the quarter ended 31 December 2019

 

 

The Income & Growth VCT plc presents an Interim Management Statement for the quarter ended 31 December 2019. The statement also includes relevant financial information between the end of the quarter and the date of this statement.

 

NET ASSET VALUE AND TOTAL RETURN PER SHARE

 

At 31 December 2019

At 30 September 2019

Net assets attributable to shareholders

£78,706,606

£81,728,079

Shares in issue

102,849,911

103,302,857

Net asset value (NAV) per share

76.53p

79.12p

Cumulative dividends paid to date per share since inception

117.50p

113.00p

Total return per share since inception (NAV basis)

194.03p

192.12p

Shareholders should note the NAV per share as at 31 December 2019 above does not include the impact of the two disposals that have occurred after the quarter end, as reported at the end of this Statement. If so, in isolation to any other factors that could affect it, the NAV per share above would increase by 1.93p.

 

CHANGE OF DIRECTORS

 

On 18 October 2019, the Company announced that, due to personal circumstances, Colin Hook was stepping down from his role as Chairman of the Board and as a director of the Company with immediate effect. The Company announced the appointment of Jonathan Cartwright, then an Independent Non-Executive Director and Chairman of the Audit Committee and Nomination and Remuneration Committee, as Chairman of the Board with immediate effect.

 

On 12 November 2019, the Company announced the appointment of Justin Ward as a Non-Executive Director of the Company. The Board appointed Justin as Chairman of both the Audit Committee and the Nomination and Remuneration Committee with immediate effect, succeeding Jonathan Cartwright in these two roles. Jonathan retained his membership of both committees.

 

On 12 February 2020, the Board announced the appointment of Maurice Helfgott as a Director and Chairman designate of the Company following Jonathan Cartwright's advice that he intends to step down as a Director and Chairman on 30 June 2020. Maurice will be appointed Chairman on 1 July 2020.

 

 

FUNDRAISING

 

On 25 October 2019, the Company launched an Offer for Subscription ("Offer") to raise, up to £5 million, with an over-allotment facility to raise up to a further £5 million. Following strong demand from investors, the Directors approved the use of the over-allotment facility on 14 December 2019. The Offer became fully subscribed on 20 December 2019 and, following the allotment of 12,939,834 new Ordinary shares on 8 January 2020, which generated net funds of £9.66 million for the Company, the Offer was formally closed.

 

DIVIDENDS

 

On 18 October 2019, the Company paid a second interim dividend of 4.50 pence per share in respect of the year ended 30 September 2019, to Shareholders on the register on 27 September 2019.

 

SHARE BUY-BACKS

 

On 13 December 2019, the Company bought back 452,946 of its Ordinary shares at a price of 70.75 pence per share.

 

All shares bought back by the Company were subsequently cancelled.

 

INVESTMENT ACTIVITY

 

New investments

On 1 November 2019, the Company made a new investment of £1.54 million into Data Discovery Solutions Limited (trading as Active Navigation), a provider of enterprise-level file analysis software.

 

On 29 November 2019, the Company made a new investment of £0.96 million into IPV Limited, a developer of media asset management software.

 

On 13 December 2019, the Company made a new investment of £0.72 million into Bleach London Holdings Limited, an established and trusted brand in the hair colourants market.

 

Divestments

On 12 December 2019, the Company sold its investment in Redline Worldwide Limited, generating cash proceeds of £1.43 million. The realisation contributed, to date, to a return over the life of the investment of 1.6 times original cost. Deferred consideration of up to £0.26 million may be received over the next 30 months.

 

Divestments after the quarter end

On 7 February 2020, the Company's investment in Pattern Analytics Limited (trading as Biosite) was sold for proceeds of £2.65 million. Over the three years that this investment was held, these proceeds contributed to a multiple on cost of 1.5 times the original cost of investment. This realisation has had no material impact on the NAV per share as reported above.

 

On 13 February 2020, the Company sold its investment in Turner Topco Limited (trading as Auction Technology Group), generating cash proceeds of £5.27 million which, combined with returns received prior to a secondary buyout in June 2014, contributed to a multiple on original cost of 4.5 times over the 11 and a half years the investment was held. In isolation, the impact of this sale on the Company's NAV per share referred to above of 76.53p, would be an increase of 1.93p.

Other than as described above, there were no material events during the quarter and to the date of this announcement.

 

Please note that all of the information above is unaudited.

 

For further information, please contact:

Mobeus Equity Partners LLP, Company Secretary: 020 7024 7600.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
MSCURVRRRNUUUAR
Date   Source Headline
9th May 202411:29 amRNSDividend Declaration - Replacement
9th May 20247:00 amRNSDividend Declaration
1st May 20247:00 amRNSTotal Voting Rights and Capital
2nd Apr 20249:32 amRNSTotal Voting Rights and Capital
28th Mar 20247:00 amRNSTransaction in Own Shares and Total Voting Rights
8th Mar 20241:00 pmRNSTransaction in Own Shares and Total Voting Rights
1st Mar 202411:00 amRNSTotal Voting Rights and Capital
29th Feb 20242:00 pmRNSResult of Annual General Meeting
28th Feb 20243:30 pmRNSMerger Discussions
27th Feb 20242:00 pmRNSRealisation of Investment: Master Removers Group
27th Feb 20249:30 amRNSInterim Management Statement
1st Feb 202411:35 amRNSVoting Rights and Capital
22nd Jan 20241:00 pmRNSTransaction in Own Shares and Total Voting Rights
15th Jan 20249:04 amRNSAnnual Financial Report
2nd Jan 20242:30 pmRNSVoting Rights and Capital
1st Dec 20237:00 amRNSTotal Voting Rights
8th Nov 202310:20 amRNSDirector/PDMR Shareholding
8th Nov 202310:15 amRNSIssue of Equity and Total Voting Rights
1st Nov 20237:00 amRNSTotal Voting Rights
12th Oct 20237:00 amRNSStatement re Change of Registrar
2nd Oct 20237:00 amRNSTotal Voting Rights
27th Sep 20234:00 pmRNSTransaction in Own Shares
25th Sep 202311:00 amRNSDividend Declaration
20th Sep 20233:30 pmRNSInterim Management Statement
1st Sep 20237:00 amRNSTotal Voting Rights
1st Aug 20237:00 amRNSTotal Voting Rights
26th Jul 20232:30 pmRNSInvestment Adviser Co-investment Incentive Scheme
3rd Jul 20237:00 amRNSTotal Voting Rights
28th Jun 202312:02 pmRNSTransaction in Own Shares
14th Jun 20237:00 amRNSHalf-year Report
1st Jun 20237:00 amRNSTotal Voting Rights
26th May 20235:15 pmRNSDirector/PDMR Shareholding
26th May 20235:00 pmRNSIssue of Equity and Total Voting Rights
26th May 20234:36 pmRNSNet Asset Value(s)
2nd May 202310:00 amRNSTotal Voting Rights
13th Apr 20231:00 pmRNSDividend Declaration
3rd Apr 20237:00 amRNSTotal Voting Rights
29th Mar 202311:00 amRNSTransaction in Own Shares
27th Mar 20231:00 pmRNSRealisation of investment:Tharstern Group Limited
3rd Mar 20235:04 pmRNSTransaction in Own Shares
1st Mar 20237:00 amRNSTotal Voting Rights
22nd Feb 20233:30 pmRNSInterim Management Statement
22nd Feb 20233:15 pmRNSResult of AGM
7th Feb 20237:01 amRNSDirector/PDMR Shareholding
7th Feb 20237:00 amRNSIssue of Equity and Total Voting Rights
1st Feb 20237:00 amRNSTotal Voting Rights
31st Jan 202311:14 amRNSIssue of Supplementary Prospectus
27th Jan 20232:00 pmRNSNet Asset Value(s)
16th Jan 20237:00 amRNSCHANGE OF ALLOTMENT DATE
11th Jan 20235:34 pmRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.